Selected research
Industry Research
Monoclonal Antibody Sequencing Industry Research Report 2026
Market perspective
The global Monoclonal Antibody Sequencing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Monoclonal Antibody Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Monoclonal Antibody Sequencing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Monoclonal Antibody Sequencing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Monoclonal Antibody Sequencing include Rapid Novor, GenScript, Labtoo, Helmholtz Munich, Molecular Cloning Laboratories, Syd Labs, Poochon, ProteoGenix and Creative Biolabs. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Monoclonal Antibody Sequencing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Monoclonal Antibody Sequencing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Monoclonal Antibody Sequencing Market by Company
Rapid Novor
GenScript
Labtoo
Helmholtz Munich
Molecular Cloning Laboratories
Syd Labs
Poochon
ProteoGenix
Creative Biolabs
Monoclonal Antibody Sequencing Segment by Type
Protein Sequencing
Gene Sequencing
Monoclonal Antibody Sequencing Segment by Application
Clinical Trials
Antibody Discovery
Vaccine Development
Other
Monoclonal Antibody Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Monoclonal Antibody Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Monoclonal Antibody Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Monoclonal Antibody Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Monoclonal Antibody Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Protein Sequencing
- Gene Sequencing
Applications
- Clinical Trials
- Antibody Discovery
- Vaccine Development
- Other
Companies covered
- Rapid Novor
- GenScript
- Labtoo
- Helmholtz Munich
- Molecular Cloning Laboratories
- Syd Labs
- Poochon
- ProteoGenix
- Creative Biolabs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Monoclonal Antibody Sequencing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Protein Sequencing
- 2.2.3 Gene Sequencing
- 2.3 Monoclonal Antibody Sequencing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Trials
- 2.3.3 Antibody Discovery
- 2.3.4 Vaccine Development
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Monoclonal Antibody Sequencing Breakdown Data by Type
- 3.1 Global Monoclonal Antibody Sequencing Historic Market Size by Type (2021-2026)
- 3.2 Global Monoclonal Antibody Sequencing Forecasted Market Size by Type (2027-2032)
4 Monoclonal Antibody Sequencing Breakdown Data by Application
- 4.1 Global Monoclonal Antibody Sequencing Historic Market Size by Application (2021-2026)
- 4.2 Global Monoclonal Antibody Sequencing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Monoclonal Antibody Sequencing Market Perspective (2021-2032)
- 5.2 Global Monoclonal Antibody Sequencing Growth Trends by Region
- 5.2.1 Global Monoclonal Antibody Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Monoclonal Antibody Sequencing Historic Market Size by Region (2021-2026)
- 5.2.3 Monoclonal Antibody Sequencing Forecasted Market Size by Region (2027-2032)
- 5.3 Monoclonal Antibody Sequencing Market Dynamics
- 5.3.1 Monoclonal Antibody Sequencing Industry Trends
- 5.3.2 Monoclonal Antibody Sequencing Market Drivers
- 5.3.3 Monoclonal Antibody Sequencing Market Challenges
- 5.3.4 Monoclonal Antibody Sequencing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Monoclonal Antibody Sequencing Players by Revenue
- 6.1.1 Global Top Monoclonal Antibody Sequencing Players by Revenue (2021-2026)
- 6.1.2 Global Monoclonal Antibody Sequencing Revenue Market Share by Players (2021-2026)
- 6.2 Global Monoclonal Antibody Sequencing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Monoclonal Antibody Sequencing Head Office and Area Served
- 6.4 Global Monoclonal Antibody Sequencing Players, Product Type & Application
- 6.5 Global Monoclonal Antibody Sequencing Manufacturers Established Date
- 6.6 Global Monoclonal Antibody Sequencing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Monoclonal Antibody Sequencing Market Size (2021-2032)
- 7.2 North America Monoclonal Antibody Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Monoclonal Antibody Sequencing Market Size by Country (2021-2026)
- 7.4 North America Monoclonal Antibody Sequencing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Monoclonal Antibody Sequencing Market Size (2021-2032)
- 8.2 Europe Monoclonal Antibody Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Monoclonal Antibody Sequencing Market Size by Country (2021-2026)
- 8.4 Europe Monoclonal Antibody Sequencing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Monoclonal Antibody Sequencing Market Size (2021-2032)
- 9.2 Asia-Pacific Monoclonal Antibody Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Monoclonal Antibody Sequencing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Monoclonal Antibody Sequencing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Monoclonal Antibody Sequencing Market Size (2021-2032)
- 10.2 South America Monoclonal Antibody Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Monoclonal Antibody Sequencing Market Size by Country (2021-2026)
- 10.4 South America Monoclonal Antibody Sequencing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Monoclonal Antibody Sequencing Market Size (2021-2032)
- 11.2 Middle East & Africa Monoclonal Antibody Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Monoclonal Antibody Sequencing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Monoclonal Antibody Sequencing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Rapid Novor
- 12.1.1 Rapid Novor Company Information
- 12.1.2 Rapid Novor Business Overview
- 12.1.3 Rapid Novor Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.1.4 Rapid Novor Monoclonal Antibody Sequencing Product Portfolio
- 12.1.5 Rapid Novor Recent Developments
- 12.2 GenScript
- 12.2.1 GenScript Company Information
- 12.2.2 GenScript Business Overview
- 12.2.3 GenScript Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.2.4 GenScript Monoclonal Antibody Sequencing Product Portfolio
- 12.2.5 GenScript Recent Developments
- 12.3 Labtoo
- 12.3.1 Labtoo Company Information
- 12.3.2 Labtoo Business Overview
- 12.3.3 Labtoo Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.3.4 Labtoo Monoclonal Antibody Sequencing Product Portfolio
- 12.3.5 Labtoo Recent Developments
- 12.4 Helmholtz Munich
- 12.4.1 Helmholtz Munich Company Information
- 12.4.2 Helmholtz Munich Business Overview
- 12.4.3 Helmholtz Munich Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.4.4 Helmholtz Munich Monoclonal Antibody Sequencing Product Portfolio
- 12.4.5 Helmholtz Munich Recent Developments
- 12.5 Molecular Cloning Laboratories
- 12.5.1 Molecular Cloning Laboratories Company Information
- 12.5.2 Molecular Cloning Laboratories Business Overview
- 12.5.3 Molecular Cloning Laboratories Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.5.4 Molecular Cloning Laboratories Monoclonal Antibody Sequencing Product Portfolio
- 12.5.5 Molecular Cloning Laboratories Recent Developments
- 12.6 Syd Labs
- 12.6.1 Syd Labs Company Information
- 12.6.2 Syd Labs Business Overview
- 12.6.3 Syd Labs Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.6.4 Syd Labs Monoclonal Antibody Sequencing Product Portfolio
- 12.6.5 Syd Labs Recent Developments
- 12.7 Poochon
- 12.7.1 Poochon Company Information
- 12.7.2 Poochon Business Overview
- 12.7.3 Poochon Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.7.4 Poochon Monoclonal Antibody Sequencing Product Portfolio
- 12.7.5 Poochon Recent Developments
- 12.8 ProteoGenix
- 12.8.1 ProteoGenix Company Information
- 12.8.2 ProteoGenix Business Overview
- 12.8.3 ProteoGenix Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.8.4 ProteoGenix Monoclonal Antibody Sequencing Product Portfolio
- 12.8.5 ProteoGenix Recent Developments
- 12.9 Creative Biolabs
- 12.9.1 Creative Biolabs Company Information
- 12.9.2 Creative Biolabs Business Overview
- 12.9.3 Creative Biolabs Revenue in Monoclonal Antibody Sequencing Business (2021-2026)
- 12.9.4 Creative Biolabs Monoclonal Antibody Sequencing Product Portfolio
- 12.9.5 Creative Biolabs Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst